EXPRESSION OF CYCLOOXYGENASE-2 IN PATIENTS WITH BLADDER CARCINOMA
- 1 May 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 165 (5) , 1468-1472
- https://doi.org/10.1016/s0022-5347(05)66329-x
Abstract
Cyclooxygenase-2 is considered to have an important role in the development of metastasis in cancer due to angiogenesis function. The expression of cyclooxygenase-2 was found to be up-regulated in colorectal carcinoma and other cancers. We investigated cyclooxygenase-1 and 2 expressions in patients with bladder cancer, chronic cystitis and normal bladder. A total of 118 specimens were obtained from patients treated at Osaka City University Hospital for bladder cancer, including 10 with chronic cystitis and 8 with normal bladder tissue. Immunohistochemistry, with affinity purified antibodies against human cyclooxygenase-1 and 2 that did not have cross-reactivity with each other, and reverse transcriptase polymerase chain reaction to study the messenger RNA expression were performed. Although no marked expression of cyclooxygenase-2 was observed in the normal bladder, it was slightly seen in infiltrative inflammatory cells of chronic cystitis, and a higher expression was found in cancer cells. The extent and intensity of immunoreactive cyclooxygenase-2 polypeptides in cancer cells was statistically much greater than those in cells from normal bladder tissue. Moreover, correlation between cyclooxygenase-2 expression and tissue type or progression of bladder cancer was observed. Cyclooxygenase-2 expression was higher in grade 3 bladder cancer than in grade 1, and was higher in advanced than in early stage cancer. These results demonstrate that generated cyclooxygenase-2 in the cells of patients with bladder cancer might be significant in the proliferation of bladder malignant cells and development of invasions.Keywords
This publication has 15 references indexed in Scilit:
- Expression of cyclooxygenase-2 in prostate carcinomaCancer, 2000
- Enhanced Expression of Cyclooxygenase-2 in High Grade Human Transitional Cell Bladder CarcinomasThe American Journal of Pathology, 2000
- Evaluating Research Studies Using the Analysis of Variance (ANOVA)Journal of Hand Therapy, 2000
- Analysis of p53, p16MTS1, p21WAF1 and H-ras in archived bladder tumours from workers exposed to aromatic aminesBritish Journal of Cancer, 1998
- Bladder cancerCurrent Opinion in Oncology, 1998
- Corticotropin releasing hormone in colonic mucosa in patients with ulcerative colitis.Gut, 1995
- Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.Journal of Clinical Investigation, 1994
- Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatmentGastroenterology, 1994
- Tumor Angiogenesis: A New Significant and Independent Prognostic Indicator in Early-Stage Breast CarcinomaJNCI Journal of the National Cancer Institute, 1992
- A protective effect of sulindac against chemically‐induced primary colonic tumours in miceThe Journal of Pathology, 1988